COVID-19: 200 Therapeutic and Vaccine Candidates


COVID-19: 200 Candidates and Counting

To navigate through the >200 potential therapeutic and vaccine options for COVID-19, GEN has grouped the candidates into four broad categories based on their developmental and (where applicable) clinical progress:

● FRONT RUNNER – the most promising therapeutics/vaccines based on clinical progress, favorable data or both.

● DEFINITELY MAYBE – earlier phases with promising partners, or more advanced candidates in development that have generated uneven data

● KEEPING AN EYE ON… – interesting technology, attracting notable partners, or both, but preliminary data.

● TOO SOON TO TELL – longshots pending additional experimental and/or clinical data.

GEN has also tagged the most common treatment types:

● ANTIVIRAL
● VAX
● ANTIBODY
● RNA

Have any Question or Comment?

Leave a Reply

Your email address will not be published. Required fields are marked *